Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy
In: Blood, Jg. 124 (2014-08-28), Heft 9, S. 1426-1433
academicJournal
Zugriff:
Titel: |
Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy
|
---|---|
Autor/in / Beteiligte Person: | Döhner, Hartmut ; Lübbert, Michael ; Fiedler, Walter ; Fouillard, Loic ; Haaland, Alf ; Brandwein, Joseph M. ; Lepretre, Stephane ; Reman, Oumedaly ; Turlure, Pascal ; Ottmann, Oliver G. ; Müller-Tidow, Carsten ; Krämer, Alwin ; Raffoux, Emmanuel ; Döhner, Konstanze ; Schlenk, Richard F. ; Voss, Florian ; Taube, Tillmann ; Fritsch, Holger ; Maertens, Johan |
Zeitschrift: | Blood, Jg. 124 (2014-08-28), Heft 9, S. 1426-1433 |
Veröffentlichung: | 2014 |
Medientyp: | academicJournal |
ISSN: | 0006-4971 (electronic) |
DOI: | 10.1182/blood-2014-03-560557 |
Sonstiges: |
|